EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Nonsteroidal-anti-inflammatories"
Narrow search

Narrow search

Year of publication
Subject
All
Nonsteroidal-anti-inflammatories 11 Osteoarthritis 6 Etoricoxib 5 Cost-utility 4 Pharmacoeconomics 4 Proton-pump-inhibitors 4 Rheumatoid-arthritis 4 Cost-effectiveness 3 Nonsteroidal anti inflammatories 3 Ankylosing-spondylitis 2 Celecoxib 2 Cost analysis 2 Cyclo-oxygenase-2-inhibitors 2 Diclofenac 2 Etanercept 2 Gastric-haemorrhage 2 Gastrointestinal disorders 2 Infliximab 2 Naproxen 2 Patient-preference 2 Quality-of-life 2 therapeutic use 2 treatment 2 Aceclofenac 1 Adalimumab 1 Adverse-reaction-monitoring 1 Ankylosing spondylitis 1 Antiulcers 1 Back-pain 1 Ciclosporin 1 Corticosteroids 1 Cost effectiveness 1 Cost-analysis 1 Cost-of-illness 1 Cyclo oxygenase 2 inhibitors 1 Diclofenac/misoprostol 1 Disease-modifying-antirheumatics 1 Duloxetine 1 Elderly 1 Epoetin-alfa 1
more ... less ...
Online availability
All
Undetermined 14
Type of publication
All
Article 14
Language
All
Undetermined 14
Author
All
Crespi, Simone 2 Hunsche, Elke 2 Kong, Sheldon X. 2 Moore, Andrew 2 Pellissier, James 2 Pellissier, James M. 2 Phillips, Ceri 2 Attard, Cheryl L. 1 Badia, Xavier 1 Birnbaum, Howard G. 1 Blumenauer, Barbara 1 Brosa, Max 1 Caloto, M.T. 1 Carracedo-Martinez, Eduardo 1 Choy, Ernest H. 1 Clinch, Jennifer 1 Conaghan, Philip G. 1 Cranney, Ann 1 Dickson, John 1 Fautrel, Bruno 1 Fraenkel, Liana 1 Fried, Terri 1 Gaugris, Sabine 1 Gaujoux-Viala, Ccile 1 Grant, Robert L. 1 Ivanova, Jasmina I. 1 Jansen, Jeroen P. 1 Joseph, Lawrence 1 Kantor, Evan 1 Latimer, Nicholas 1 LeLorier, Jacques 1 Lord, Joanne 1 Marentette, Michael A. 1 Marshall, John K. 1 Martinez, Eduard 1 Matías-Guiu, J. Matas-Guiu 1 Nash, Julian T. 1 Nocea, G. 1 O'Mahony, Rachel OMahony 1 Ostor, Andrew 1
more ... less ...
Published in...
All
PharmacoEconomics 12 The Patient: Patient-Centered Outcomes Research 2
Source
All
RePEc 14
Showing 1 - 10 of 14
Cover Image
Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review
Gaujoux-Viala, Ccile; Fautrel, Bruno - In: PharmacoEconomics 30 (2012) 12, pp. 1145-1156
Objectives:Objectives: This report reviews the cost effectiveness of different therapeutic interventions used in the treatment of ankylosing spondylitis (AS). Abstract: Methods:Methods: We performed a systematic search of the databases MEDLINE via PubMed, EMBASE and the Cochrane Library and used...
Persistent link: https://www.econbiz.de/10011005078
Saved in:
Cover Image
Comparison of Expected Outcomes between Patients and Neurologists Using Kano's Methodology in Symptomatic Migraine Treatment
Matías-Guiu, J. Matas-Guiu; Caloto, M.T.; Nocea, G. - In: The Patient: Patient-Centered Outcomes Research 5 (2012) 3, pp. 147-162
Objectives:Objectives: Our objective was to evaluate the potential usefulness of the Kano conceptual model to assess expectations of patients and neurologists in Spain regarding symptomatic migraine treatment. Abstract: Methods:Methods: We performed a multicenter, cross-sectional study in adult...
Persistent link: https://www.econbiz.de/10011005083
Saved in:
Cover Image
Duloxetine Use in Chronic Low Back Pain: Treatment Patterns and Costs
Ivanova, Jasmina I.; Birnbaum, Howard G.; Kantor, Evan; … - In: PharmacoEconomics 30 (2012) 7, pp. 595-609
Background:Background: Little is known about the real-world treatment patterns and costs of patients with chronic low back pain (CLBP) who are treated with duloxetine compared with those receiving other non-surgical treatments. Abstract: Objective:Objective: Our objective was to compare the...
Persistent link: https://www.econbiz.de/10010551726
Saved in:
Cover Image
Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
Latimer, Nicholas; Lord, Joanne; Grant, Robert L.; … - In: PharmacoEconomics 29 (2011) 3, pp. 225-237
Background: Recent National Institute for Health and Clinical Excellence (NICE) guidance recommended that when traditional NSAIDs or cyclo-oxygenase (COX)-2 selective inhibitors are used by people with osteoarthritis (OA), they should be prescribed along with a proton pump inhibitor (PPI)....
Persistent link: https://www.econbiz.de/10011005081
Saved in:
Cover Image
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
Jansen, Jeroen P.; Gaugris, Sabine; Choy, Ernest H.; … - In: PharmacoEconomics 28 (2010) 4, pp. 323-344
Objectives: To evaluate the cost effectiveness of etoricoxib (90 mg/day) relative to celecoxib (200 or 400 mg/day), and the non-selective NSAIDs naproxen (1000 mg/day) and diclofenac (150 mg/day) in the initial treatment of ankylosing spondylitis (AS) from the UK NHS perspective....
Persistent link: https://www.econbiz.de/10008602827
Saved in:
Cover Image
If You Want Patients with Knee Osteoarthritis to Exercise, Tell Them about NSAIDs
Fraenkel, Liana; Fried, Terri - In: The Patient: Patient-Centered Outcomes Research 1 (2008) 1, pp. 21-26
Objective: Exercise is an important adjunctive treatment for knee osteoarthritis (OA); however, it is underutilized, in part because of the known difficulties related to initiating and adhering to exercise programs. Although there are ample data documenting the latter, patient preferences for...
Persistent link: https://www.econbiz.de/10005242980
Saved in:
Cover Image
Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
Carracedo-Martinez, Eduardo - In: PharmacoEconomics 23 (2005) 7, pp. 743-743
Persistent link: https://www.econbiz.de/10005449136
Saved in:
Cover Image
The Authors' Reply
Moore, Andrew; Phillips, Ceri; Hunsche, Elke; … - In: PharmacoEconomics 23 (2005) 7, pp. 743-745
Persistent link: https://www.econbiz.de/10005449210
Saved in:
Cover Image
Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
Moore, Andrew; Phillips, Ceri; Hunsche, Elke; … - In: PharmacoEconomics 22 (2004) 10, pp. 643-660
Introduction: The objective of this study was to evaluate the potential economic implications of using etoricoxib versus non-selective NSAID alternatives in the treatment of patients with osteoarthritis (OA) or rheumatoid arthritis (RA) in the UK. Study design: Decision-analytical modelling was...
Persistent link: https://www.econbiz.de/10005449127
Saved in:
Cover Image
Assessing the Economic Impact of Adverse Drug Effects
Rodriguez-Monguio, Rosa; Otero, Maria Jose; Rovira, Joan - In: PharmacoEconomics 21 (2003) 9, pp. 623-650
Although most commonly used drugs cause adverse effects, some of them with potentially serious consequences, relatively little is known about their economic impact. The purpose of this review is to summarise information describing the cost of treatment of drug-induced adverse effects as an...
Persistent link: https://www.econbiz.de/10005404829
Saved in:
  • 1
  • 2
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...